DepoDur FDA Approval History
FDA Approved: Yes (Discontinued) (First approved May 18, 2004)
Brand name: DepoDur
Generic name: morphine sulfate
Dosage form: extended-release liposome Injection
Company: SkyePharma PLC and Endo Pharmaceuticals
Treatment for: Pain
Marketing Status: Discontinued
DepoDur (morphine sulfate extended-release liposome injection) is an opiate for the treatment of pain following major surgery.
Development timeline for DepoDur
| Date | Article |
|---|---|
| May 18, 2004 | Approval DepoDur SkyePharma PLC and Endo Pharmaceuticals - Treatment for Post-Surgical Pain Relief |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
